Health Condition 1: L408- Other psoriasis
Conditions
Interventions
Intervention1: Topical 5-fluorouracil (1%): 5-flourouracil is a cytostatic and immunomodulatory compound. Topical application of 5- Flourouracil (1%) over psoriatic lesions for overnight application (
Sponsors
Dr Prateek Chauhan
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria Patients with Lesions covering more than 30% of palms/soles (palmoplantar psoriasis). Patients age >18 years. Patients who give their consent for the study.
Exclusion criteria
Exclusion criteria: Exclusion criteria Patients of age Patients with psoriatic lesions where systemic therapy is needed. Pregnant and Breast feeding females. Patients who had taken topical anti-psoriatic medication in 2 weeks or more before enrollment. Patients who had taken systemic anti-psoriatic medication in 1 month or more before enrollment. Patients who didnâ??t give their consent for the study or have not shown willingness for follow up. Patients on oral steroids or immunosuppressing agents.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Morphology of lesions Duration of disease Size of lesion Infiltration Erythema Desquamation PASI score Timepoint: O weeks 2 weeks 4 weeks 6 weeks 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| PASI SCORETimepoint: 0 weeks 2 weeks 4 weeks 6 weeks 8 weeks | — |
Countries
India
Contacts
Public ContactDr Prateek Chauhan
Peoples college of medical science and research centre
Outcome results
None listed